Quick Answer
Regen BioPharma Inc reported Total Revenue of $236.6 thousand for fiscal year 2025.
Regen BioPharma Inc Total Revenue — Annual History
| Fiscal Year | Total Revenue | YoY Change |
|---|---|---|
| 2025 | $236.6K | +0.0% |
| 2024 | $236.6K | +86.9% |
| 2023 | $126.6K | +0.8% |
| 2022 | $125.5K | +105.1% |
| 2021 | $61.2K | -44.4% |
| 2020 | $110.0K | +0.0% |
| 2019 | $110.0K | +10.0% |
| 2018 | $100.0K | -9.1% |
| 2017 | $110.0K | +10.0% |
| 2016 | $100.0K | -47.9% |
| 2015 | $192.0K | — |
| 2014 | $0.00 | — |
Quarterly Total Revenue
| Quarter Ending | Total Revenue | YoY | QoQ |
|---|---|---|---|
| December 31, 2025 | $59.1K | +0.0% | +0.0% |
| June 30, 2025 | $59.1K | +0.0% | +0.0% |
| March 31, 2025 | $59.1K | +86.7% | +0.0% |
| December 31, 2024 | $59.1K | +86.7% | +0.0% |
| June 30, 2024 | $59.1K | +0.0% | +86.7% |
| March 31, 2024 | $31.6K | +0.0% | +0.0% |
| December 31, 2023 | $31.6K | +0.0% | -46.4% |
| June 30, 2023 | $59.1K | +88.8% | +86.7% |
- Regen BioPharma Inc showed an increase of +0.0% in Total Revenue compared to the prior fiscal year.
- The most recent figure is from Regen BioPharma Inc’s fiscal year 2025 report (Form 10-K), filed with the SEC on December 30, 2025.
- All figures are sourced from SEC EDGAR XBRL filings, last verified June 17, 2026.
Last verified: